Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Explore well-known S&P 500 index funds for retirement 2024, focusing on performance, costs, and suitability for your plan.
22,695 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
AMD’s latest earnings call highlights a rapid AI-led growth wave and a massive server CPU opportunity. Here are the f...
When Palantir reveals new AI-focused capabilities, Nvidia stock often faces a unique set of pressures. This guide bre...
RadNet is entering 2026 with a mix of imaging volumes, payer dynamics, and technology investments. This guide breaks ...
As May 14 approaches, investors weigh growth momentum, profitability, and AI competition around figma's next earnings...
Dutch Bros has grown from a regional coffee shop to a national sensation. This article weighs the case for dutch bros...
Supreme Lending adds a Houston-based team with over $100 million in annual loan production, strengthening its Texas f...
Cardano has struggled to deliver on big promises, leaving many investors looking for cryptocurrencies that better buy...
Solana surged 13% last week, its strongest performance of 2026, driven by ETF demand and higher futures activity. Tra...
Oil prices cooled modestly on May 14, 2026, with Brent trading around $107.82 per barrel. Analysts say the current pr...
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Figma trades higher ahead of tonight’s Q1 print, as analysts eye revenue growth and AI momentum. Live coverage tracks...